PUBLISHER: The Business Research Company | PRODUCT CODE: 1946710
PUBLISHER: The Business Research Company | PRODUCT CODE: 1946710
Oxygen conserving devices (OCDs) are medical devices designed to optimize oxygen delivery for patients with respiratory conditions. These devices minimize oxygen wastage by delivering it only during inhalation, rather than continuously, thus extending the life of oxygen tanks or concentrators.
The main types of oxygen conserving devices include reservoir cannulas, transtracheal catheters, intermittent flow devices, continuous flow devices, and other products. A reservoir cannula is a type of nasal cannula that stores additional oxygen in a small chamber during exhalation. Oxygen-conserving devices are used to treat various conditions such as chronic obstructive pulmonary disease (COPD), pneumonia, asthma, and other respiratory disorders. They are utilized by different end-users, including hospitals and clinics, long-term care units, home care settings, and others.
Tariffs are impacting the oxygen conserving devices market by increasing costs of imported sensors, regulators, electronic modules, and medical-grade plastics used across intermittent and continuous flow devices. Healthcare facilities in North America and Europe are most affected due to dependency on imported components, while Asia-Pacific faces cost escalation in manufacturing and exports. These tariffs are raising overall device costs and slowing replacement cycles. However, they are also supporting domestic production, regional assembly operations, and development of locally sourced oxygen delivery solutions.
The oxygen conserving devices market research report is one of a series of new reports from The Business Research Company that provides oxygen conserving devices market statistics, including oxygen conserving devices industry global market size, regional shares, competitors with a oxygen conserving devices market share, detailed oxygen conserving devices market segments, market trends and opportunities, and any further data you may need to thrive in the oxygen conserving devices industry. This oxygen conserving devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The oxygen conserving devices market size has grown rapidly in recent years. It will grow from $1.91 billion in 2025 to $2.2 billion in 2026 at a compound annual growth rate (CAGR) of 15.4%. The growth in the historic period can be attributed to increasing incidence of chronic respiratory diseases, expansion of home healthcare infrastructure, rising demand for portable oxygen therapy, improved access to oxygen delivery systems, growing awareness of oxygen conservation benefits.
The oxygen conserving devices market size is expected to see rapid growth in the next few years. It will grow to $3.86 billion in 2030 at a compound annual growth rate (CAGR) of 15.1%. The growth in the forecast period can be attributed to increasing demand for smart respiratory devices, rising adoption of wearable oxygen solutions, expansion of aging population care services, growing focus on cost-effective oxygen therapy, increasing technological advancements in oxygen delivery. Major trends in the forecast period include increasing adoption of intermittent flow oxygen delivery, rising use of portable oxygen conserving devices, growing integration of smart oxygen control mechanisms, expansion of home and long-term care oxygen solutions, enhanced focus on oxygen efficiency.
The expanding healthcare infrastructure is anticipated to drive the growth of the oxygen conserving devices market in the coming years. Healthcare infrastructure encompasses the physical and organizational structures, facilities, systems, and resources necessary for the effective delivery of healthcare services. This infrastructure is growing as the rising prevalence of chronic diseases, such as diabetes and cardiovascular conditions, fuels demand for specialized care facilities and resources to manage long-term patient needs. Healthcare infrastructure facilitates the use of oxygen conserving devices by ensuring consistent access, efficient delivery, and proper maintenance in both medical facilities and home-care settings. For example, in October 2025, ScienceSoft USA Corporation, a U.S.-based consulting and software development firm, reported that as of 2023, the United States had a total of 6,093 hospitals, including 5,112 community hospitals. Of these community hospitals, 2,978 are nonprofit, 1,214 are for-profit, and 920 are government-operated. Consequently, the growth of healthcare infrastructure is contributing to the expansion of the oxygen conserving devices market.
Major companies operating in the oxygen-conserving devices market are emphasizing energy-efficient oxygen delivery solutions, such as solar-compatible, low-power oxygen concentrators designed for unstable or resource-limited electrical environments. These devices are engineered to deliver consistent oxygen output while minimizing energy use and enabling operation in areas where conventional power sources are unreliable. Typically, such systems feature wide-voltage input capability, soft-start circuitry, and robust components to ensure dependable performance under challenging conditions. For example, in October 2024, Drive DeVilbiss Healthcare, a U.S.-based respiratory-care company, launched the PulmO2 Oxygen Concentrator. The device offers up to 67% lower energy consumption, supporting sustained use in low-resource settings, a soft-start design for compatibility with solar power systems to enable off-grid operation, and a wide input voltage range (100-240 VAC) with strong environmental tolerance, ensuring reliable performance in high heat, humidity, dust, and at altitudes up to 2,000 meters.
In July 2025, ESAB Corporation, a U.S.-based provider of fabrication and gas-control solutions with a growing medical gas control and oxygen therapy devices segment, acquired Aktiv Technologies for an undisclosed sum. Through this acquisition, ESAB Corporation aims to expand and strengthen its global medical gas control portfolio by integrating Aktiv Technologies' expertise in medical central gas systems, flowmeters, and regulators. The deal is expected to increase manufacturing capacity, enhance the company's presence in high-growth markets such as India, and support its broader offerings of oxygen therapy and oxygen-conserving devices for hospitals and other healthcare providers worldwide. Aktiv Technologies is an India-based manufacturer of medical central gas systems and pipeline equipment, including flowmeters and oxygen-conserving devices, serving healthcare facilities.
Major companies operating in the oxygen conserving devices market are Medline Industries LP, Drive DeVilbiss Healthcare LLC, React Health, GF Health Products Inc., Essex Industries Inc., Compass Health Brands, Sunset Healthcare Solutions Inc., CHAD Therapeutics, Precision Medical Inc., Air Liquide Healthcare, Inovo Inc., HERSILL, GCE Group, Responsive Respiratory Inc., Caire Inc., Inogen Inc., Philips Respironics, ResMed Inc., Fisher & Paykel Healthcare, Oxus America, Longfian Scitech Co. Ltd., Beijing North Star Medical Equipment Co. Ltd.
North America was the largest region in the oxygen conserving devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the oxygen conserving devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the oxygen conserving devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The oxygen conserving devices market consists of sales of pulse-dose oxygen conservers, continuous-flow oxygen conservers, electronic oxygen conservers, pneumatic oxygen conservers, and reservoir cannulas. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Oxygen Conserving Devices Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses oxygen conserving devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for oxygen conserving devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The oxygen conserving devices market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.